EULAR pediatric sessions to highlight big data, personalized medicine

Dr. Swart, who helped pioneer the approach, will discuss the first phase I/II trial of its use in children. “This is a truly innovative way to handle refractory inflammation,” Dr. Prakken said.

The session on monogenic autoinflammatory diseases also will cover their clinical presentation in children and adults, their pathogenesis as compared with adult-onset rheumatic diseases, and emerging treatment options, according to Dr. Prakken.

On Friday afternoon, a pediatric session will feature big data science in pediatric rheumatology, a lightning-paced field that is generating new research and treatment paradigms.

Of special note, Salvatore Albani, MD, PhD, will discuss how the human immunome is revolutionizing personalized treatment of paediatric inflammatory diseases, Dr. Prakken said. “This is the first application of big data to develop a completely new, personalized map of the human immune system,” he added. “This technology has the potential to revolutionize human clinical immunology, and it may be the key to true precision medicine in inflammatory diseases.”